treatment

Poll

Poll: Dermatologic and Rheumatologic Manifestations in IBD

09/08/2020

Which treatment-related manifestation has led you to change your therapeutic approach to patients with inflammatory bowel disease (IBD)? Let us know by taking our poll.

Which treatment-related...

09/08/2020

Advances in Inflammatory Bowel Disease Network

Conference Coverage

Treat-To-Target Approach for Inflammatory Bowel Disease

08/22/2020

Applying a systematic treat-to-target approach is effective for reducing the risk of long-term complications in patients with IBD, but incremental benefit must be evaluated. Siddarth Singh, MD, spoke about this topic at today’s AIBD 2020...

Applying a systematic...

08/22/2020

Advances in Inflammatory Bowel Disease Network

Conference Coverage

Diagnosing and Managing C difficile Infection in Patients With IBD

07/29/2020

Even among patients without pre-existing gastrointestinal disease, Clostridioides difficile is often debilitating. In patients with inflammatory bowel disease, it can be very serious. Jessica Allegretti, MD, explained the steps to diagnosing...

Even among patients without...

07/29/2020

Advances in Inflammatory Bowel Disease Network

Videos

Russell Cohen, MD, on Defining the Target to Treat in IBD

07/25/2020

Russell Cohen, MD, reviews his presentation from the virtual AIBD regional meeting July 25 on defining the target to treat in inflammatory bowel disease.

Russell Cohen, MD, reviews his...

07/25/2020

Advances in Inflammatory Bowel Disease Network

Videos

Stephen Hanauer, MD, on Positioning JAK Inhibitors in IBD

07/25/2020

He discusses the positioning of JAK inhibitors in the treatment of inflammatory bowel disease, which he presented at the virtual AIBD regional meeting July 25.

He discusses the positioning of...

07/25/2020

Advances in Inflammatory Bowel Disease Network

Conference Coverage

Positioning Therapeutic Agents for IBD

07/24/2020

The many different classes of medications available for treating inflammatory bowel disease give gastroenterologists more options than ever before—and also more challenges in determining how to balance efficacy and safety. Miguel Regueiro,...

The many different classes of...

07/24/2020

Advances in Inflammatory Bowel Disease Network

Conference Coverage

Treating IBD Without TNFis and JAKs

07/24/2020

The treatment of inflammatory bowel disease has changed dramatically since the introduction of biologics and small molecule therapeutics. But does that mean older therapies no longer have any role? David Rubin, MD, offered his views at the...

The treatment of inflammatory...

07/24/2020

Advances in Inflammatory Bowel Disease Network

Videos

Preview: Russell Cohen, MD, on Defining the Target to Treat in IBD

07/23/2020

Dr Cohen, director of the Inflammatory Bowel Disease Center at UChicago Medicine, previews his talk for the virtual Advances in Inflammatory Bowel Disease regional meeting July 25.

Dr Cohen, director of the...

07/23/2020

Advances in Inflammatory Bowel Disease Network

Podcasts

ANA Investigates Cannabis and Cannabinoids for MS Symptoms

07/20/2020

Michelle Cameron, MD, PT, talks about the federal and state legalities surrounding cannabinoid use, how cannabinoids go through the FDA approval process, and how cannabinoids can be used to treat symptoms of multiple sclerosis.

Michelle Cameron, MD, PT, talks...

07/20/2020

Neurology

Videos

Ryan Ungaro, MD, on Treat-to-Target: Is It All About the Mucosa?

06/30/2020

Ryan Ungaro, MD, of the Icahn School of Medicine at Mt. Sinai in New York, gives a recap of his presentation on treat-to-target in IBD from the virtual Advances in Inflammatory Bowel Disease 2020 regional meeting on June 27.

Ryan Ungaro, MD, of the Icahn...

06/30/2020

Advances in Inflammatory Bowel Disease Network